Tue.May 28, 2024

article thumbnail

All-New Comprehensive Skin Remodeling System

Lipgloss and Aftershave

FACTORFIVE Debuts Renew Dermal Solution (RDS). The FACTORFIVE Renewal Dermal Solution is the first comprehensive skin remodeling system. FACTORFIVE® is introducing the first comprehensive skin remodeling system, Renew Dermal Solution. A new patent-pending treatment that combines professional chemical exfoliation with FACTORFIVE’s human stem cell factors for a safe, simple, effective, and predictable treatment.

article thumbnail

Top 4 Advances Transforming Acne Vulgaris Treatment in 2024

MedEsthetics

Since the recent update of the AAD's acne management guidelines in January, exciting treatment innovations seeking to target the source of the problem have been explored, including new formulations and surgical approaches.

article thumbnail

The Vitality Project Provides Revolutionary Wellness Solution for the Beauty Industry

Beauty Launchpad

Launched by Elizabeth Faye, The Vitality Project offers a plug & play wellness program that serves as a tool to address the industry challenges beauty professionals face daily.

Tools 98
article thumbnail

Innersense Organic Beauty Revolutionizes Professional Hair Color with Launch of Color Purity

Salon Today

With the launch of Color Purity, Innersense Organic Beauty sets a new standard for clean, safe, and effective high-performance hair color systems

105
105
article thumbnail

Top 3 Advances in Professional Intimate Skin Care for Women

MedEsthetics

89% of readers want to learn about innovations in professional intimate skin care for women! Here are the top three advances in professional intimate skin care for women.

article thumbnail

'All Hands on Deck' for Hidradenitis Suppurativa: HS Foundation Spotlights Advocacy, Education Initiatives

Dermatology Times

Hadar Lev-Tov, MD, MAS, President of the HS Foundation, discusses the organization's hopes for the future and upcoming efforts.

More Trending

article thumbnail

Innovent's Picankibart (IBI112) Achieves Phase 3 Clinical Success in Moderate to Severe Plaque Psoriasis

Dermatology Times

Based on these findings, Innovent plans to submit a New Drug Application to the Center for Drug Evaluation of National Medical Product Administration.

article thumbnail

Why Continuing Education Is Vital for Success in Esthetics

Estelle Skin Care

Continuing education is a crucial component in the journey to success for estheticians. At Estelle Skin Care and Spa Institute, our commitment to providing top-tier esthetician courses in Illinois extends to offering advanced education opportunities for licensed estheticians. In this … Continue reading → The post Why Continuing Education Is Vital for Success in Esthetics first appeared on Estelle Skin Care & Spa Institute.

article thumbnail

Efficacy of Risankizumab For Severe Psoriasis

Dermatology Times

The study not only showed success for patients with severe psoriasis, but also suggested it may be worth trying before other biologics.

74
article thumbnail

Master Your Future with Laser Technician Training in Nashville

National Laser Institute

Are you looking to embark on a personally and professionally rewarding career in medical aesthetics? National Laser Institute has a. Read more » The post Master Your Future with Laser Technician Training in Nashville appeared first on National Laser Institute.

article thumbnail

POLL: What Would You Like to Learn from the 2024 Fall Clinical Dermatology Conference for PAs and NPs?

Dermatology Times

Whether you are attending in-person or looking to Dermatology Times coverage, let us know which topics interest you most.

article thumbnail

Meet Lane Cook: Beauty Launchpad 30 Over 30 Winner for 2024

Beauty Launchpad

Get to know Lane Cook (@myhairmagick). She is a hairstylist and owner of My Hair Magick Studio in Puyallup, WA.

52
article thumbnail

Master Your Future with Laser Technician Training in Nashville

National Laser Institute

Are you looking to embark on a personally and professionally rewarding career in medical aesthetics? National Laser Institute has a. Read more » The post Master Your Future with Laser Technician Training in Nashville appeared first on National Laser Institute.

article thumbnail

Health Canada Accepts Arcutis Canada's Submission for Roflumilast Cream 0.15% in Atopic Dermatitis

Dermatology Times

Supportive data for roflumilast in adults and children 6 years of age and older stems from the INTEGUMENT studies.

article thumbnail

Can’t Tolerate Retinol? Try These 6 Great Alternatives

West Lake Dermatology

Patients who are considering a change to their skin care routine have likely encountered one of today’s most popular ingredients: Retinol. Praised for its ability to combat signs of aging, acne, and uneven skin tone, retinol has become a staple in many skincare routines. However, despite its numerous benefits, retinol is not always the best fit for everyone.

Retinol 36
article thumbnail

AARS Offers Social Toolkit to Help Spread #AcneFacts During National Acne Awareness Month

The Dermatology Digest

The American Acne and Rosacea Society is spotlighting members’ stories about their experiences living with, treating, and studying acne to spread accurate medical information during National Acne Awareness Month in June. All month, AARS members will address the impact of acne on affected individuals, dispel myths, and discuss treatment options. AARS social platforms will include updates in June and throughout the summer.

article thumbnail

The Role of Pharmacists in Skin Care Education in the Age of Social Media

Dermatology Times

Social media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.

article thumbnail

CSU Pipeline Watch: First Patient Dosed in Phase 1 Trial of Allakos’s AK006

The Dermatology Digest

The first patient with chronic spontaneous urticaria (CSU) has been dosed in Allakos Inc.’s Phase 1 trial of AK006. AK006 is a humanized IgG1 monoclonal antibody which activates the inhibitory receptor Siglec-6. Siglec-6 is found on the surface of mature mast cells and offers a way to selectively target mast cells. In preclinical experiments, AK006 inhibits IgE-dependent and IgE-independent mast cell activation including activation through IgE, MRGPRX2, and KIT receptors.

Safety 36